• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

2021 Cochrane Review: Intervention vs Expectant Management for Miscarriage

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Ghosh et al. (Cochrane Database of Systematic Reviews, 2021) estimated the relative effectiveness and safety profiles for the different management methods for early miscarriage

METHODS:

  • Systematic review and meta-analysis
  • Inclusion criteria
    • RCTs
    • Studies that examined the effectiveness or safety of methods for miscarriage management
  • Study design
    • Early miscarriage: ≤14 weeks of gestation (including missed and incomplete)
    • Certainty of evidence was assessed using GRADE criteria
    • Relative effects for the primary outcomes are reported subgrouped by the type of miscarriage (incomplete and missed miscarriage)
    • To determine the relative effects and rankings of all available methods, the authors performed pairwise meta-analyses and network meta-analysis
  • Primary outcome
    • Complete miscarriage
    • Composite outcome of death or serious complications

RESULTS:

  • 78 trials | 17,795 women
  • Trial arms: 158
    • Misoprostol: 33% of trial arms
    • Suction aspiration: 32%
    • Expectant management or placebo: 16%
    • Dilatation and curettage: 11%
    • Mifepristone plus misoprostol: 6%
    • Suction aspiration plus cervical preparation: 2%

Primary Outcome: Complete Miscarriage

  • 59 trials | 12,591 women
  • Five methods may be more effective than expectant management or placebo for achieving a complete miscarriage
    • Suction aspiration after cervical preparation
      • RR 2.12 (95% CI, 1.41 to 3.20); low-certainty evidence
    • Dilatation and curettage
      • RR 1.49 (95% CI, 1.26 to 1.75); low‐certainty evidence
    • Suction aspiration
      • RR 1.44 (95% CI, 1.29 to 1.62); low‐certainty evidence
    • Mifepristone plus misoprostol
      • RR 1.42 (95% CI, 1.22 to 1.66); moderate‐certainty evidence
    • Misoprostol
      • RR 1.30 (95% CI, 1.16 to 1.46); low‐certainty evidence
  • The highest ranked
    • Surgical method: suction aspiration after cervical preparation
    • Non-surgical method: mifepristone plus misoprostol
  • All surgical methods were ranked higher than medical methods
  • Subgroup analyses by type of miscarriage (missed or incomplete) agreed with the overall analysis—surgical methods were the most effective treatment, followed by medical methods and then expectant management or placebo
    • However, there are possible subgroup difference in the effectiveness of the available methods
  • Planned subanalysis of ≤9 weeks vs >9 weeks was not doable
    • Only 5 trials specified gestational age <9 weeks

Primary Outcome: Composite Outcome of Death And Serious Complications

  • 35 trials | 8161 women
    • No deaths were reported
    • Composite outcome entirely composed of serious complications (e.g. blood transfusions, uterine perforations, hysterectomies, and ICU admissions)
  • Majority of complications were related to blood transfusions | Uterine perforation was also documented  
  • Data too limited to derive conclusion
    • However, expectant management or placebo was associated with more serious complications vs interventions

CONCLUSION:

  • The authors state

Surgical methods were ranked highest for managing a miscarriage, followed by medical methods, which in turn ranked above expectant management or placebo

Expectant management or placebo had the highest chance of serious complications, including the need for unplanned or emergency surgery

The type of miscarriage (incomplete vs missed) may contribute to inconsistency and heterogeneity in the data, and will be explored further in a future update 

Learn More – Primary Sources:

Methods for managing miscarriage: a network meta-analysis

Want to stay on top of key guidelines and research papers?

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Managing Early Pregnancy Loss
MifeMiso RCT results: Mifepristone Plus Misoprostol or Misoprostol Alone for Miscarriage Treatment?
Expectant Management vs Misoprostol for the Treatment of Miscarriage
Is Surgical Evacuation Needed Following Incomplete Miscarriage?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site